Hereditary ATTR amyloidosis: a single-institution experience with 266 patients
Authors:
- David B. ZhenDZDavid B. Zhen
- Michelle L. MauermannMMMichelle L. Mauermann
- Robert A. KyleRKRobert A. Kyle
- Steven R. ZeldenrustSZSteven R. Zeldenrust
- Martha GroganMGMartha Grogan
- Angela DispenzieriADAngela Dispenzieri
- Morie A. GertzMGMorie A. Gertz
- 16 December 2014
- journal article
- Published by Taylor & Francis in Amyloid
- Vol. 22 (2) , 123-131
Abstract
Hereditary transthyretin amyloidosis (ATTR amyloidosis) is a rare, clinically heterogeneous disease due to heritable mutations that lead to misfolding of a precursor protein and multisystem disease. This study sought to define the clinical characteristics, distribution of mutations and phenotypic presentation of patients presenting to our center with hereditary ATTR amyloidosis. With institutional review board approval, the study retrospectively identified patients who had hereditary ATTR amyloidosis and presented to Mayo Clinic in Rochester, Minnesota, from 1 January 1970, to 29 January 2013. Of the 266 patients with the diagnosis of hereditary ATTR amyloidosis, a pathogenic mutation was identified in 206; the most common mutation was Thr60Ala (68 patients [25%]). Median age at diagnosis was 63.3 years; median survival after diagnosis was 56.8 months (10th-90th percentile, 16.0-297.9). On multivariate analysis, age at diagnosis (risk ratio, 15.65; p < 0.0001), Thr60Ala mutation (risk ratio, 1.52; p = 0.04), Val122Ile mutation (risk ratio, 2.83; p = 0.003), peripheral neuropathy (risk ratio, 1.69; p = 0.013) and weight loss (risk ratio, 1.81; p = 0.002) were risk factors for death. Our data characterize the features of hereditary ATTR amyloidosis in a large cohort, demonstrate the heterogeneity among mutations and support the need to better characterize the clinical progression of individual mutations.Keywords
This publication has 19 references indexed in Scilit:
- Genotype, echocardiography, and survival in familial transthyretin amyloidosisAmyloid, 2013
- THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosisCurrent Medical Research and Opinion, 2012
- Genotype – phenotype correlation in FAPAmyloid, 2012
- Familial amyloid polyneuropathyThe Lancet Neurology, 2011
- Familial transthyretin-type amyloid polyneuropathy in JapanNeurology, 2002
- Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in JapanBrain, 1999
- Familial Amyloidotic Polyneuropathy in Sweden: Geographical Distribution, Age of Onset, and PrevalenceHuman Heredity, 1993
- Generalized Amyloid in a Family of Swedish OriginAnnals of Internal Medicine, 1977
- Polyneuritic Amyloidosis in a Japanese FamilyArchives of Neurology, 1968
- A PECULIAR FORM OF PERIPHERAL NEUROPATHYBrain, 1952